Science Inventory

BY HOW MUCH DO SHAPES OF TOXICOLOGICAL DOSE-RESPONSE RELATIONSHIPS VARY? (SOT)

Citation:

Slob, W. AND Woodrow Setzer. BY HOW MUCH DO SHAPES OF TOXICOLOGICAL DOSE-RESPONSE RELATIONSHIPS VARY? (SOT). Presented at Society of Toxicology, Phoenix, AZ, March 23 - 27, 2014. https://doi.org/10.23645/epacomptox.5193223

Impact/Purpose:

Dose-response assessment, as a part of risk assessment, requires that the shape of the dose-response curve be used as part of the information used for hazard characterization. To the extent that the shape of the dose-response curve is unknown, the uncertainty of hazard characterization is increased. This research explores the extent to which the shape of dose-response curves can be taken as known.

Description:

A re-analysis of a large number of historical dose-response data for continuous endpoints showed that the shapes of the dose-response relationships were surprisingly homogenous. The datasets were selected on the sole criterion that they were expected to provide relatively good information on the dose-response shape, and included a variety of endpoints and both in vivo and in vitro studies of various types. Both the four-parameter exponential and Hill model adequately described all toxicological dose-response data we considered. For a given endpoint and study type, dose-response shapes did not differ statistically significantly among chemicals in the in vitro studies considered, while a mild among-chemical variation in the steepness parameter seemed to be present in the in vivo studies. These findings have various practical consequences. For continuous endpoints, model selection in the BMD approach is not a crucial issue. The often-applied approach of using constraints on the model parameters to prevent “infinite” slope at dose zero in fitting a model is not in line with our findings, and appears to be unjustified. Instead, more realistic ranges of parameter values could be derived from re-analyses of large numbers of historical dose-response datasets in the same endpoint and study type, which would then be used as parameter constraints or informative priors in the analysis of future individual datasets. This approach would be particularly useful for weak datasets (e.g. few doses, much scatter). In addition, this approach may open the way to use fewer animals in future studies. Finally, we argue that distinctions between linear, sub/supralinear or thresholded dose-response shapes, based on visual inspection of plots, are not biologically meaningful nor useful for risk assessment. This abstract does not necessarily reflect EPA policy.

Record Details:

Record Type:DOCUMENT( PRESENTATION/ POSTER)
Product Published Date:03/27/2014
Record Last Revised:08/19/2014
OMB Category:Other
Record ID: 284198